US Patent Issued to Kalivir Immunotherapeutics on Nov. 18 for "Platform oncolytic vector for systemic delivery" (Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,217, issued on Nov. 18, was assigned to Kalivir Immunotherapeutics Inc. (Pittsburgh).

"Platform oncolytic vector for systemic delivery" was invented by Stephen H. Thorne (Pittsburgh), Daniel J. Byrd (Pittsburgh) and Mingrui Zhang (Pittsburgh).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides a modified oncolytic virus that can contain modifications in the viral genome and exogenous nucleic acids coding for proteins. The modified oncolytic virus can be utilized as a platform vector for systemic delivery."

The patent was filed on Jan. 14, 2022, under Application No. 17/575,787.

*For further information, including images, charts ...